iCardio.ai gets FDA 510(k) clearance for AI echocardiography
Leave a CommentThe algorithms are used to detect valvular heart disease.
Read the full article at: www.mobihealthnews.com
The algorithms are used to detect valvular heart disease.
Read the full article at: www.mobihealthnews.com
[𝐈𝐝𝐚𝐡𝐨, 𝐔𝐒𝐀] – Rapid Response Diagnostics, a division of the Beto Paredes Family of Companies, is excited to announce the launch of its advanced software platforms designed to enhance medical practices through innovative patient intake, underpayment auditing, diagnostics, and patient…
Read the full article at: web3wire.org
Detection and management of diseases are two of the most important functions that in vitro diagnostic devices provide in the rapidly developing field of healthcare. Biological samples are analyzed by these machines, which provide information that is necessary for clinical decision-writing.
Read the full article at: pi123.org
/PRNewswire/ — Accure Acne, Inc.™ (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today that…
Read the full article at: www.prnewswire.com
Patient advocates hope Dr. Michelle Tarver will lead the agency to focus more on safety and less on rapid approvals.
Read the full article at: biztoc.com
Nvision Biomedical Technologies, a San Antonio-based medical device and implant manufacturer, in collaboration with Invibio Biomaterial Solutions, a global leader in high-performance biomaterials, has received FDA clearance for the first 3D-printed porous PEEK Interbody System.
Read the full article at: 3dprintingindustry.com
/PRNewswire/ — Bracco Diagnostics Inc., a U.S. subsidiary of Bracco Imaging S.p.A, one of the world’s leading companies in the diagnostic imaging business,…
Read the full article at: www.prnewswire.com
/PRNewswire/ — Natus Medical Incorporated announced it has submitted an FDA 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for…
Read the full article at: www.prnewswire.com
/PRNewswire/ — Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an innovator of rapid in vitro diagnostics, announced that the U.S. Food and Drug Administration…
Read the full article at: www.prnewswire.com
The FDA approved Novocure medical device Optune Luna as a treatment for advanced cases of non-small cell lung cancer. The wearable technology delivers electrical fields that kill cancer cells.
Read the full article at: medcitynews.com